Chen Zhao

This inventor holds 17 USPTO granted patents and 22 published patent applications, plus 5 CIPO patents and 14 EPO patents, primarily in Genetic Sequencing. Top assignees: Illumina Corporation, Sequenom, Inc.. Active years: 2020-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chen Zhao. Retrieved from https://idiyas.com/inventor/chen-zhao-wafwxlco

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 (Patent Applications = 22)

% Patents Active = 88.2

CIPO Patents = 5 (Patent Applications = 18)

EPO Patents = 14 (Patent Applications = 24)

Average Co-Inventor Count = 3.8

ph-index = 4

Forward Citations = 28(Granted Patents)

Company Filing History:

Years Active: 2020-2026

Loading Chart...

Areas of Expertise:

Genetic Variations

Tumor Detection

Cell-Free DNA

Sequence Variant

Unique Molecular Identifiers

Error-Correction

Genetic Copy Number

Molecular Index Sets

Sequencing Reads

Non-Invasive Assessment

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12763165 - Methods and processes for non-invasive assessment of genetic variations (2026-10-13),

2. 12603149 - Validation methods and systems for sequence variant calls (2026-04-14),

3. 12230365 - Systems and methods for grouping and collapsing sequencing reads (2025-02-18),

4. 12087401 - Using cell-free DNA fragment size to detect tumor-associated variant (2024-09-10),

5. 12040047 - Validation methods and systems for sequence variant calls (2024-07-16),

6. 11898198 - Universal short adapters with variable length non-random unique molecular identifiers (2024-02-13),

7. 11783911 - Methods and processes for non-invasive assessment of genetic variations (2023-10-10),

8. 11761035 - Methods and systems for generation and error-correction of unique molecular index sets with heterogeneous molecular lengths (2023-09-19),

9. 11688489 - Systems and methods for grouping and collapsing sequencing reads (2023-06-27),

10. 11462298 - Methods and processes for non-invasive assessment of genetic variations (2022-10-04),

11. 11447818 - Universal short adapters with variable length non-random unique molecular identifiers (2022-09-20),

12. 11342047 - Using cell-free DNA fragment size to detect tumor-associated variant (2022-05-24),

13. 11200963 - Genetic copy number alteration classifications (2021-12-14),

14. 10930368 - Methods and processes for non-invasive assessment of genetic variations (2021-02-23),

15. 10892035 - Methods and processes for non-invasive assessment of genetic variations (2021-01-12),

Title: Innovations of Inventor Chen Zhao

Introduction

Chen Zhao is a prominent inventor based in San Diego, CA, known for his significant contributions to the field of biotechnology. He holds a total of 15 patents, showcasing his innovative approach to solving complex problems in genetic sequencing and analysis.

Latest Patents

Among his latest patents is a system and method for grouping and collapsing sequencing reads. This invention discloses systems and methods for collapsing sequencing reads and identifying similar sequencing reads. In one example, the method includes generating a plurality of first identifier subsequences from a first identifier sequence of each nucleotide sequencing read and generating a first signature for the nucleotide sequencing read by applying hashing to the plurality of first identifier subsequences. The method may also include assigning the nucleotide sequencing read to a first particular bin of a first data structure based on the first signature and determining a nucleotide sequence for each first particular bin of the first data structure with one or more nucleotide sequencing reads assigned.

Another notable patent involves using cell-free DNA fragment size to detect tumor-associated variants. This invention provides methods and systems for determining a variant of interest by analyzing sizes and sequences of cfDNA fragments obtained from a test sample. The methods and systems implement processes that synergistically combine size and sequence information, thereby improving specificity and sensitivity of assays over conventional methods.

Career Highlights

Chen Zhao has worked with leading companies in the biotechnology sector, including Illumina Corporation and Sequenom, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in genetic research and diagnostics.

Collaborations

Throughout his career, Chen has collaborated with notable professionals in the field, including Cosmin Deciu and Kevin Eric Wu. These collaborations have further enhanced his work and led to significant advancements in the technologies he has developed.

Conclusion

In summary, Chen Zhao is a distinguished inventor whose work has greatly impacted the field of biotechnology. His innovative patents and collaborations reflect his commitment to advancing genetic research and improving diagnostic methods.

Profile summary based on public USPTO records.